EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Infection model of THP-1 cells, growth dynamics, and antimicrobial susceptibility of clinical Mycobacterium abscessus isolates from cystic fibrosis patients: Results from a multicentre study

Alba Ruedas-López iD, Marta Tato, Laura Lerma, Jaime Esteban, María-Carmen Muñoz-Egea, Carlos Toro, Diego Domingo, Rafael Prados-Rosales, Paula López-Roa

PLOS ONE · 31.03.2025 · 20 (3) · e0319710

DOI: 10.1371/journal.pone.0319710 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift PLOS ONE, online erschienen am 31.03.2025. Verfasst von Alba Ruedas-López und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Microbiology and Parasitology Department, Hospital Universitario 12 de Octubre, Madrid, Spain. Hauptthemen laut MEDLINE: Cystic Fibrosis, Mycobacterium abscessus, Mycobacterium Infections, Nontuberculous, Anti-Bacterial Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Instituto de Salud Carlos III, Instituto Nacional de Salud.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycobacterium abscessus (MABS) is an emerging pathogen causing severe infections, particularly in cystic fibrosis (CF) patients. A prospective multicentre study included CF patients from four hospitals in Madrid between January 2022 and January 2024. Respiratory samples were collected, and MABS isolates were analysed to determine their antibiotic resistance profiles, growth dynamics, infection kinetics, intracellular behaviour, and pathogenicity. Intracellular bacterial growth and macrophage viability were evaluated through THP-1 cell infection experiments, with and without amikacin. Phenotypic susceptibility testing and genotypic susceptibility testing were also conducted. Among 148 patients, 28 MABS isolates were detected from 16 patients (10.8%), and the first isolate from each patient was analysed. Isolation was more prevalent in younger individuals (median age 24.4 vs. 28.4 years, p = 0.049), and most isolates (81.25%) were identified as M. abscessus subsp. abscessus (MABSa) . MABS isolates exhibited high resistance rates (>85%) to doxycycline, tobramycin, ciprofloxacin, moxifloxacin (75%) and cotrimoxazole (56.3%). Amikacin resistance (18.8%) was higher than expected, and inducible (10/16 isolates) or acquired (1/16 isolate) macrolide resistance was found in 68.8% of strains. Phenotypic and genotypic testing results were fully concordant. Tigecycline demonstrated strong in vitro activity, and resistance to imipenem, linezolid, and cefoxitin remained low. Rough strains displayed lower optical density values in later growth stages, probably due to their increased aggregation. In THP-1 cell infection experiments, rough strains showed higher intracellular bacterial loads with statistically significant differences observed at 2 hours (both with and without amikacin) and at 72 hours (with amikacin) post infection. Notably, rough strains also exhibited a higher internalisation index and greater impact on THP-1 cell viability, especially in the absence of amikacin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisMycobacterium abscessusMycobacterium Infections, NontuberculousAnti-Bacterial AgentsHumansTHP-1 CellsFemaleMicrobial Sensitivity TestsAdultMaleProspective StudiesYoung AdultAdolescentAmikacinChildDrug Resistance, Bacterial

Substanzen

Anti-Bacterial AgentsAmikacin

Autor:innen und Institutionen

  • Clinical Microbiology and Parasitology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Department of Preventive Medicine, Public Health and Microbiology, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
  • Clinical Microbiology and Parasitology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • .Clinical Microbiology Department, IIS-Fundación Jiménez Díaz, UAM. Madrid, Spain.
  • CIBERINFEC-CIBER de Enfermedades Infecciosas, Madrid, Spain.
  • Clinical Microbiology and Parasitology Department, Hospital Universitario La Paz, Madrid, Spain.

ORCID-Profile: Alba Ruedas-López

Förderung

  • NIAID NIH HHS
  • Instituto de Salud Carlos III
  • Instituto Nacional de Salud
  • Ministerio de Ciencia e Innovación

Zitieren

APA

Ruedas-López, A., Tato, M., Lerma, L., Esteban, J., Muñoz-Egea, M. C., Toro, C., Domingo, D., Prados-Rosales, R., & López-Roa, P. (2025). Infection model of THP-1 cells, growth dynamics, and antimicrobial susceptibility of clinical Mycobacterium abscessus isolates from cystic fibrosis patients: Results from a multicentre study. PLOS ONE, 20(3), e0319710. https://doi.org/10.1371/journal.pone.0319710

Vancouver

Ruedas-López A, Tato M, Lerma L, Esteban J, Muñoz-Egea MC, Toro C, et al. Infection model of THP-1 cells, growth dynamics, and antimicrobial susceptibility of clinical Mycobacterium abscessus isolates from cystic fibrosis patients: Results from a multicentre study. PLOS ONE. 2025;20(3):e0319710. doi:10.1371/journal.pone.0319710

BibTeX
@article{RuedasLpez2025,
  author = {Ruedas-López, Alba and Tato, Marta and Lerma, Laura and Esteban, Jaime and Muñoz-Egea, María-Carmen and Toro, Carlos and Domingo, Diego and Prados-Rosales, Rafael and López-Roa, Paula},
  title = {Infection model of THP-1 cells, growth dynamics, and antimicrobial susceptibility of clinical Mycobacterium abscessus isolates from cystic fibrosis patients: Results from a multicentre study},
  journal = {PLOS ONE},
  year = {2025},
  volume = {20},
  number = {3},
  pages = {e0319710},
  doi = {10.1371/journal.pone.0319710}
}
Kostenlos starten →